Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice.
Hioe CE, Li G, Liu X, Tsahouridis O, He X, Funaki M, Klingler J, Tang AF, Feyznezhad R, Heindel DW, Wang XH, Spencer DA, Hu G, Satija N, Prévost J, Finzi A, Hessell AJ, Wang S, Lu S, Chen BK, Zolla-Pazner S, Upadhyay C, Alvarez R, Su L.
Hioe CE, et al. Among authors: spencer da.
PLoS Pathog. 2022 Jan 5;18(1):e1010183. doi: 10.1371/journal.ppat.1010183. eCollection 2022 Jan.
PLoS Pathog. 2022.
PMID: 34986207
Free PMC article.